Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Fanchao Feng"'
Autor:
Tingyu Pan, Le Bai, Dongwei Zhu, Yun Wei, Qi Zhao, Fanchao Feng, Zhichao Wang, Yong Xu, Xianmei Zhou
Publikováno v:
PLoS ONE, Vol 19, Iss 4, p e0300423 (2024)
BackgroundNumerous metabolomic studies have confirmed the pivotal role of metabolic abnormalities in the development of idiopathic pulmonary fibrosis (IPF). Nevertheless, there is a lack of evidence on the causal relationship between circulating meta
Externí odkaz:
https://doaj.org/article/ee634e638f484d63845b3d4fd248a47b
Autor:
Fanchao Feng, Jingyi Huang, Zhichao Wang, Jiarui Zhang, Di Han, Qi Wu, Hailang He, Xianmei Zhou
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 20, Iss 1, Pp 1-15 (2020)
Abstract Background Xiao-ai-ping injection (XAPI), as patented Chinese medicine, has shown promising outcomes in non-small-cell lung cancer (NSCLC) patients. This meta-analysis investigated the efficacy and safety of XAPI in combination with platinum
Externí odkaz:
https://doaj.org/article/90aeade767c640f4852f884ecb35a005
Autor:
Na Xiao MD, Hailang He MD, Jing Wang MD, Li Zhang MD, Brandon Chow, Fanchao Feng MD, Yong Xu MD, Jingyi Huang MD, Xianmei Zhou MD, Rui Dong MD
Publikováno v:
Journal of Evidence-Based Integrative Medicine, Vol 26 (2021)
The combination of Aidi injection (ADI) and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in treating non-small cell lung cancer (NSCLC) has been reported, but the effects of this therapy have not been systematically assessed.
Externí odkaz:
https://doaj.org/article/714ea6e321bf48bd9111968b8d1e0ef8
Autor:
Fanchao Feng, Zhichao Wang, Ruofei Li, Qi Wu, Cheng Gu, Yong Xu, Wenpan Peng, Di Han, Xianmei Zhou, Jing Wu, Hailang He
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 112, Iss , Pp - (2019)
Idiopathic pulmonary fibrosis (IPF) is a progressive and ultimately fatal lung disease with a poor prognosis and limited treatment options. The incidence of IPF increases with age, and the mechanisms related to aging such as cellular senescence have
Externí odkaz:
https://doaj.org/article/adda58571d74430b91fc07de8b657ab3
Autor:
Rilei Jiang, Bing Lu, Fanchao Feng, Qian Li, Xiaolei Chen, Shibing Cao, Zhaoxia Pan, Zhengming Deng, Yufei Zhou, Ping Liu, Jiatuo Xu
Publikováno v:
Cell Proliferation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0cc5384bf4c1189583c3d5e7f29e3ee
https://doi.org/10.1111/cpr.13402
https://doi.org/10.1111/cpr.13402
Publikováno v:
Phytomedicine. 112:154680
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef8d1acb7d60dae0cfa01fcfdc8b9fa4
https://doi.org/10.1016/j.phymed.2023.154680
https://doi.org/10.1016/j.phymed.2023.154680
Publikováno v:
Evidence-based complementary and alternative medicine : eCAM. 2022
Background. Aidi injection (ADI) is a compound preparation injection of Chinese herbs used to treat patients of nonsmall cell lung cancer (NSCLC) in China. This study aimed to reveal the mechanism of ADI in the treatment of NSCLC by using network pha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::726058c567a5deeec8d080724c7af339
https://pubmed.ncbi.nlm.nih.gov/36523419
https://pubmed.ncbi.nlm.nih.gov/36523419
Publikováno v:
Clinical Rehabilitation. 34:1004-1013
Objective: To objectively evaluate the effectiveness of Baduanjin exercise on cardiopulmonary function and quality of life in chronic obstructive pulmonary disease patients. Data sources: Articles published in PubMed, EMBASE, China National Knowledge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c84a2824e8d3423be0d3b981f93f1ab3
https://doi.org/10.1177/0269215520926635
https://doi.org/10.1177/0269215520926635
Publikováno v:
Experimental and Therapeutic Medicine
Maiwei Yangfei (MWYF) is a compound Chinese herb that is safe and effective in the clinical setting in patients with pulmonary fibrosis (PF). The aim of the present study was to assess the role of a (MWYF) decoction in a bleomycin (BLM)-induced PF mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20ff549936002029ae6bd7e3c5ee3a14
https://doi.org/10.3892/etm.2021.10741
https://doi.org/10.3892/etm.2021.10741
Publikováno v:
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-Based Complementary and Alternative Medicine, Vol 2021 (2021)
Evidence-Based Complementary and Alternative Medicine, Vol 2021 (2021)
Background. Cinobufacini capsule, an anticancer traditional Chinese patent medicine, has been widely used as adjunctive treatment to platinum-based chemotherapy in patients with advanced NSCLC. Purpose. To evaluate the efficacy and safety of cinobufa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f8621545fac2dd9d278dda0b9f9a721
http://europepmc.org/articles/PMC8405304
http://europepmc.org/articles/PMC8405304